Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis

Jahnavi Udaikumar, Sushrut Ingawale, Rithish Nimmagadda, Satwik Kuppili, Vindhya Vasini Lella, Tarun Kumar Suvvari, Abraham Cheloff, Amulya Bellamkonda, Suprabhat Giri, Paul Oberstein, Aasma Shaukat · 2025

Read Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: a systematic review and meta-analysis by Jahnavi Udaikumar, Sushrut Ingawale, Rithish Nimmagadda, Satwik Kuppili, Vindhya Vasini Lella, Tarun Kumar Suvvari, Abraham Cheloff, Amulya Bellamkonda, Suprabhat Giri, Paul Oberstein, Aasma Shaukat (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12780613.txt.

Description

Udaikumar and a team of co-authors review the evidence on fruquintinib, a drug for colorectal cancer that has spread and stopped responding to earlier treatments. The drug blocks receptors that help tumors grow new blood vessels. The review asks how well it works and how safe it is, alone and with immune therapy drugs.

Fifteen studies were gathered, and twelve of them, covering 3,703 patients, were combined in a meta-analysis. Fruquintinib lengthened both time without growth and overall survival compared with placebo, while side effects were common, most often high blood pressure and hand-foot skin reactions. The authors conclude the drug is a useful later-line option, with combination benefits still unproven.

Catalog record

CREATORJahnavi Udaikumar, Sushrut Ingawale, Rithish Nimmagadda, Satwik Kuppili, Vindhya Vasini Lella, Tarun Kumar Suvvari, Abraham Cheloff, Amulya Bellamkonda, Suprabhat Giri, Paul Oberstein, Aasma Shaukat
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12780613

Browse the full library · About the Tower of Babel